Previously, Genentech, a subsidiary of Roche, announced that its Valcyte (valganciclovir hydrochloride) had been approved by the U.S. Food and Drug Ad···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 104
The price of anagrelide is affected by factors such as specifications, region, and medical insurance policies. In the domestic market, the price typic···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 101
The price of anagrelide (anagrelide hydrochloride) varies depending on its strength, dosage form, purchase channel, and region; imported versions may ···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 95
The price of anagrelide (anagrelide hydrochloride) varies depending on its strength, dosage form, purchase channel, and region; imported versions may ···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 95
The price of ibrutinib is affected by dosage, region, and medical insurance policies. The specific price per box usually depends on the doctor's p···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 98
The price of ibrutinib varies significantly depending on the region and version purchased. This variation primarily stems from the influence of health···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 102
Ibrutinib is a targeted drug used to treat hematologic malignancies such as lymphoma and leukemia, and it belongs to the BTK inhibitor class. Its pric···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 94
Takeda Pharmaceutical recently presented updated data from a Phase 1/2 clinical trial of its oral targeted anticancer drug mobocertinib (TAK-788) for ···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 89
Takeda Pharmaceutical recently announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review its New Drug Applic···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 88
Summary: EGFR Exon20ins+ non-small cell lung cancer (NSCLC) is an extremely rare cancer, primarily affecting young adults and non-smokers. Its prognos···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 90
On September 15, 2021, Takeda Pharmaceutical Company of Japan announced accelerated approval from the FDA for Exkivity (mobocertinib) for the treatmen···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 90
Recently, the UK's National Institute for Health and Care Excellence (NICE) released its final guidelines, recommending Exkivity (Mobocertinib) fo···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 89
The price of Upadacitinib varies by region, dosage specification, and purchasing channel. In domestic public hospitals or formal pharmacies, it is gen···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 101
The price of utpatinib varies depending on specifications, purchase channels, and region. As a prescription drug, it must be used strictly according t···【Read More】
Update: 2026-03-19Source: Haiou HealthViews: 93
Upatinib is a prescription drug, and its price varies depending on the drug strength (e.g., 15mg/tablet), region, medical institution, and medical ins···【Read More】
Update: 2026-03-19Source: Haiou HealthViews: 97
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



